Miteva M, Tosti A (2012) Hair and scalp dermatoscopy
10.1016/j.cbi.2020.108968 [DOI] [PubMed] [Google Scholar] 52.Bliddal H, Bays H, Czernichow S, Udden Hemmingsson J, Hjelmesaeth J, Hoffmann Morville T, Koroleva A, Skov Neergaard J, Velez Sanchez P, Wharton S, Wizert A, Kristensen LE, Group SS (2024) Once-weekly semaglutide in persons with obesity and knee osteoarthritis
Other potential risks include pancreatitis, gallbladder disease, diabetic retinopathy complications (with semaglutide), and acute kidney injury if dehydration occurs
Understanding the formulation It is important to know that compounded medications, such as semaglutide with B12, are not an FDA-approved drug